Unknown

Dataset Information

0

Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

ABSTRACT: Congenital adrenal hyperplasia is a category of disorders characterized by impaired adrenocortical steroidogenesis. The most frequent disorder of congenital adrenal hyperplasia is 21-hydroxylase deficiency, which is caused by pathogenic variants of CAY21A2 and is prevalent between 1 in 18,000 and 20,000 in Japan. The clinical guidelines for 21-hydroxylase deficiency in Japan have been revised twice since a diagnostic handbook in Japan was published in 1989. On behalf of the Japanese Society for Pediatric Endocrinology, the Japanese Society for Mass Screening, the Japanese Society for Urology, and the Japan Endocrine Society, the working committee updated the guidelines for the diagnosis and treatment of 21-hydroxylase deficiency published in 2014, based on recent evidence and knowledge related to this disorder. The recommendations in the updated guidelines can be applied in clinical practice considering the risks and benefits to each patient.

SUBMITTER: Ishii T 

PROVIDER: S-EPMC9297175 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

Ishii Tomohiro T   Kashimada Kenichi K   Amano Naoko N   Takasawa Kei K   Nakamura-Utsunomiya Akari A   Yatsuga Shuichi S   Mukai Tokuo T   Ida Shinobu S   Isobe Mitsuhisa M   Fukushi Masaru M   Satoh Hiroyuki H   Yoshino Kaoru K   Otsuki Michio M   Katabami Takuyuki T   Tajima Toshihiro T  

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 20220410 3

Congenital adrenal hyperplasia is a category of disorders characterized by impaired adrenocortical steroidogenesis. The most frequent disorder of congenital adrenal hyperplasia is 21-hydroxylase deficiency, which is caused by pathogenic variants of <i>CAY21A2</i> and is prevalent between 1 in 18,000 and 20,000 in Japan. The clinical guidelines for 21-hydroxylase deficiency in Japan have been revised twice since a diagnostic handbook in Japan was published in 1989. On behalf of the Japanese Socie  ...[more]

Similar Datasets

Unknown Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.
| S-EPMC9001848 | biostudies-literature
Unknown Novel rapid molecular diagnosis methods for comprehensive genetic analysis of 21-hydroxylase deficiency.
| S-EPMC11514819 | biostudies-literature
Unknown Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
| S-EPMC9545286 | biostudies-literature
Unknown Clinical characteristics and treatment during preconception and perinatal period of infertile women with non-classical 21-hydroxylase deficiency.
| S-EPMC11443925 | biostudies-literature
Unknown Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA.
| S-EPMC5547133 | biostudies-literature
Unknown The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.
| S-EPMC8360643 | biostudies-literature
Unknown Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021.
| S-EPMC8116006 | biostudies-literature
Unknown POR polymorphisms are associated with 21 hydroxylase deficiency.
| S-EPMC8421294 | biostudies-literature
Unknown Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency.
| S-EPMC4922339 | biostudies-literature
Unknown Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision).
| S-EPMC9887297 | biostudies-literature